KDM6B and breast carcinoma: Depending on cancer type, JMJD3 expression is increased (prostate and breast cancers, melanoma, gliomas, renal cell carcinoma [10, 20–24]) or decreased (lung, liver, pancreatic, colon and colorectal cancers [25–27]).